Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Am J Transplant ; 14(12): 2874-82, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25394722

RESUMO

Human CD4(+) CD25(+) FoxP3(+) regulatory T cells (Tregs) prevent allogeneic graft rejection by inhibiting T cell activation, as has been shown in mouse models. Recently, low-dose IL-2 administration was shown to specifically activate Tregs but not pathogenic conventional T cells, leading to resolution of type 1 diabetes in nonobese diabetic mice. We therefore tested the ability of low-dose IL-2 to prevent allogeneic skin graft rejection. We found that while IL-2 alone was inefficient in preventing rejection, combined with rapamycin, IL-2 treatment promoted skin graft survival both in minor disparate and semi-allogeneic skin graft combinations. Tregs are activated by this combined treatment while conventional CD4(+) cell expansion and activation are markedly inhibited. Co-administration of anti-CD25 antibodies dramatically reduces the effect of the IL-2/rapamycin treatment, strongly supporting a central role for Treg activation. Thus, we provide the first preclinical data showing that low-dose IL-2 combined with rapamycin can significantly delay transplant rejection in mice. These findings may form the rational for clinical evaluation of this novel approach for the prevention of transplant rejection.


Assuntos
Rejeição de Enxerto/prevenção & controle , Sobrevivência de Enxerto , Imunossupressores/administração & dosagem , Interleucina-2/administração & dosagem , Sirolimo/administração & dosagem , Transplante de Pele , Animais , Antineoplásicos/administração & dosagem , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Citometria de Fluxo , Humanos , Técnicas Imunoenzimáticas , Ativação Linfocitária/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Complicações Pós-Operatórias , Linfócitos T Reguladores/efeitos dos fármacos , Linfócitos T Reguladores/imunologia , Tolerância ao Transplante , Transplante Homólogo
3.
Rev Med Brux ; 31(3): 149-56, 2010.
Artigo em Francês | MEDLINE | ID: mdl-20687441

RESUMO

A concrete realisation of the "Geriatric assessment and management program" as described in the arrêté royal within a general hospital: definition of the geriatric patient, his detection, his follow-up and the transmission of patient information. The analysis of the first results indicates the importance of the biographic and socio-economics factors. The optimisation of an early screening and the communication between caregivers are key aspects to enhance the care of this patients.


Assuntos
Avaliação Geriátrica , Idoso , Bélgica , Hospitalização , Hospitais Gerais , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...